Search results for "Atrial Fibrillation"
New antibiotic approved for hospital-acquired pneumonia
The FDA approved sulbactam and durlobactam for injection to treat hospital-acquired or ventilator-associated pneumonia caused by susceptible strains of Acinetobacter baumannii-calcoaceticus complex, among other recent actions.
https://acphospitalist.acponline.org/archives/2023/07/05/new-antibiotic-approved-for-hospital-acquired-pneumonia.htm
5 Jul 2023
Switching to newer oral anticoagulant didn't benefit frail older patients with afib
A randomized trial that switched some frail atrial fibrillation patients from vitamin K antagonists (VKAs) to non-vitamin K oral anticoagulants found that such patients had more bleeding and no decrease in thromboembolic events compared to those who stayed on a VKA.
https://acphospitalist.acponline.org/archives/2023/09/06/switching-to-newer-oral-anticoagulant-didnt-benefit-frail-older-patients-with-afib.htm
6 Sep 2023
Apixaban linked to lower risk of serious bleeding compared to warfarin in patients with or without afib
A comparison of direct oral anticoagulants and warfarin found that apixaban had the lowest number needed to treat to avoid one extra major bleed compared to warfarin, while rivaroxaban had the lowest number needed to harm with death from bleeding.
https://acphospitalist.acponline.org/weekly/archives/2018/07/11/3.htm
11 Jul 2018
MKSAP quiz on stroke
This month's quiz includes questions from ACP's Medical Knowledge Self-Assessment Program (MKSAP 18) on stroke.
https://acphospitalist.acponline.org/archives/2020/08/mksap-quiz-on-stroke.htm
15 Aug 2020
RSV vaccine, OTC naloxone approved
The FDA also updated the prescribing information for immediate-release opioid pain medicines to note that these products should not be used for an extended period, among other recent actions.
https://acphospitalist.acponline.org/archives/2023/05/24/rsv-vaccine-otc-naloxone-approved.htm
24 May 2023
Decision pathway addresses bleeding in patients on oral anticoagulants
The guidance from the American College of Cardiology covers management of major and minor bleeding in patients treated with direct-acting oral anticoagulants or vitamin K antagonists for any indication.
https://acphospitalist.acponline.org/weekly/archives/2020/07/22/4.htm
22 Jul 2020
In-hospital mortality for afib patients appears higher in rural vs. urban hospitals
The electrophysiology and medical communities should look at the findings as a motivational call to initiate prospective studies with the goal of identifying gaps in afib care, an accompanying editorial said.
https://acphospitalist.acponline.org/weekly/archives/2017/12/20/3.htm
20 Dec 2017
Interrupting DOACs for surgery associated with low rates of major bleeding, clots in afib patients
The standardized strategy stopped direct oral anticoagulants (DOAC) for one to two days prior to an elective surgery or procedure and resumed DOACs one to three days afterward, without heparin bridging, in patients with atrial fibrillation.
https://acphospitalist.acponline.org/weekly/archives/2019/08/14/3.htm
14 Aug 2019
Continuing aspirin for no reason?
A speaker made the case for anticoagulant monotherapy in selected patients with stable coronary artery disease and atrial fibrillation during a “Things We Do For No Reason” session at SHM Converge 2022.
https://acphospitalist.acponline.org/archives/2022/04/27/continuing-aspirin-for-no-reason.htm
27 Apr 2022
Bridging with heparin after stroke associated with worse outcomes than not bridging
Both ischemic and bleeding events within 90 days of stroke were more common among patients with nonvalvular atrial fibrillation who received full-dose low-molecular-weight heparin when starting a direct oral anticoagulant or warfarin.
https://acphospitalist.acponline.org/weekly/archives/2019/07/03/2.htm
3 Jul 2019